Policy | February 02, 2023
Budget 2023-24: Industry welcomes focus on medical research and pharma innovation
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Study introduces structured, condition-specific emergency coding system to improve coordination, response time, and patient safety in tertiary care hospitals
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
Subscribe To Our Newsletter & Stay Updated
